ImmunoPrecise Antibodies Ltd (IPA) NPV

Sell:$1.83Buy:$1.86$0.16 (8.08%)

Prices delayed by at least 15 minutes
Sell:$1.83
Buy:$1.86
Change:$0.16 (8.08%)
Prices delayed by at least 15 minutes
Sell:$1.83
Buy:$1.86
Change:$0.16 (8.08%)
Prices delayed by at least 15 minutes

Company Information

About this company

ImmunoPrecise Antibodies Ltd. is a biotherapeutic research company. It is advancing Bio-Native AI at the intersection of biology and computation. Its LENSai and HYFT platforms enable large-scale reasoning across sequence, structure, function, and scientific literature, powering workflows across drug discovery, diagnostics, vaccine design, and molecular systems biology. The core of its operations encompasses a diverse suite of proprietary technologies that aid in the exploration, discovery, and development of novel drugs and biologics. Integrated within its wet lab infrastructure is a diverse array of in silico technologies. As an end-to-end service provider of antibody discovery and development, its computational methodologies allow the Company to perform detailed and comprehensive evaluations across various stages of biologic discovery and development. It is involved in antibody characterization studies, which encompass affinity measurements, epitope landscape profiling, and others.

Key people

Mitch Levine
Chairman of the Board
Jennifer Lynne Bath
President, Chief Executive Officer, Director
Joseph Scheffler
Interim Chief Financial Officer
Ilse Roodink
Chief Scientific Officer
Kari Graber
Vice President - Commercial Services
Lisa Helbling
Director
Kamil Isaev
Director
Jonathan I. Lieber
Director
Robert D. Burke
Independent Director
Barry A. Springer
Independent Director
Click to see more

Key facts

  • EPIC
    IPA
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    CA45257F2008
  • Market cap
    $90.61m
  • Employees
    102
  • Shares in issue
    45.77m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.